CAS: 54-62-6 - Aminopterin

Formel: C₁₉H₂₀N₈O₅

InChl: InChI=1S/C19H20N8O5/c20-15-14-16(27-19(21)26-15)23-8-11(24-14)7-22-10-3-1-9(2-4-10)17(30)25-12(18(31)32)5-6-13(28)29/h1-4,8,12,22H,5-7H2,(H,25,30)(H,28,29)(H,31,32)(H4,20,21,23,26,27)/t12-/m0/s1

InChI Key: InChIKey=TVZGACDUOSZQKY-LBPRGKRZSA-N

SMILES: O=C(O)CCC(NC(=O)C1=CC=C(C=C1)NCC=2N=C3C(=NC2)N=C(N=C3N)N)C(=O)O

Synonyme:

• (2S)-2-[[4-[(2,4-Diaminopteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
• 4-Amino-4-Deoxypteroylglutamate
• 4-Amino-Folicaci
• 4-Amino-Pga[Qr]
• 4-Aminofolic Acid
• 4-Aminofolicacid[Qr]
• 4-Aminopteroylglutamic acid
• 4-Aminopteroylglutamicacid[Qr]
• 4-Diamino-6-Pteridinyl)Methyl)Amino)Benzoyl)-N-(P-(((L-Glutamicaci
• <span class="text-smallcaps">L</span>-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-
• Acide N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-L-glutamique
• Agpa
• Ai3-26079[Qr]
• Aminopterin
• Aminopterine
• Apga
• Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, <span class="text-smallcaps">L</span>-
• Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, L-
• L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-
• N-(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
• N-(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}benzoyl)glutamic acid
• N-[(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}phenyl)carbonyl]-D-glutamic acid
• N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]amino]benzoyl]-<span class="text-smallcaps">L</span>-glutamic acid
• N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]amino]benzoyl]-L-glutaminsaure
• N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
• Nsc 739
• Pteramina
• Pteridin-2-Amine
• acido N-[4-[[(2,4-diamino-6-pteridinil)metil]amino]benzoil]-L-glutamico

Methotrexate Related Compound B ((S)-2-{4-[(2,4-diaminopteridin-6-yl)methylamino]benzamido}pentanedioic acid)

CAS: 54-62-6

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …

• Formel: C₁₉H₂₀N₈O₅
• Farbe und Form: White Yellow Powder
• Molekulargewicht: 440.41

L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-

CAS: 54-62-6

• Formel: C₁₉H₂₀N₈O₅
• Farbe und Form: Solid
• Molekulargewicht: 440.4127

Aminopterin dihydrate

CAS: 54-62-6

• Formel: C₁₉H₂₀N₈O₅·xH₂O
• Reinheit: ≥ 97.0%
• Farbe und Form: Pale yellow to yellow-brown powder
• Molekulargewicht: 440.41 (anhydrous)

Aminopterin

CAS: 54-62-6

• Formel: C₁₉H₂₀N₈O₅
• Reinheit: >97.0%(T)(HPLC)
• Farbe und Form: White to Amber powder to crystal
• Molekulargewicht: 440.42

(2S)-2-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]amino]benzoyl]amino]pentanedioic Acid (4-Aminofolic Acid, Aminopterin)

CAS: 54-62-6

• Formel: C₁₉H₂₀N₈O₅
• Farbe und Form: Neat
• Molekulargewicht: 440.41

Methotrexate EP Impurity B

CAS: 54-62-6

• Formel: C₁₉H₂₀N₈O₅
• Molekulargewicht: 440.42

Aminopterin

CAS: 54-62-6

Aminopterin (4-Aminofolic acid) is a synthetic folic acid derivative whose metabolite is a competitive inhibitor …

• Formel: C₁₉H₂₀N₈O₅
• Reinheit: ≥95%
• Farbe und Form: Orange-Yellow Powder Rodenticide In The U S (Epa 1998)
• Molekulargewicht: 440.41

Aminopterin

CAS: 54-62-6

Impurity Methotrexate EP Impurity B Applications Aminopterin (Methotrexate EP Impurity B) is a folic acid …

• Formel: C₁₉H₂₀N₈O₅
• Farbe und Form: Yellow
• Molekulargewicht: 440.41

Aminopterin

CAS: 54-62-6

Aminopterin is a nitrogen mustard drug that is used as an immunosuppressant in the treatment …

• Formel: C₁₉H₂₀N₈O₅
• Reinheit: Min. 97 Area-%
• Farbe und Form: Slightly Yellow Powder
• Molekulargewicht: 440.41 g/mol